| |
|
|
|
|
|
|
|||
|
Blood, Vol. 93 No. 3 (February 1), 1999:
pp. 1116-1118
CORRESPONDENCE To the Editor:
The article by Carreau et al1 reports on the in vivo
effects of mitomycin C (MMC) in mice carrying the Fanconi anemia (FA) group C mutation (Fac A role for oxidative stress in FA has been documented for two decades,
with reports providing evidence for an improvement of either
chromosomal instability or cell growth after exposure of either primary
lymphocyte cultures or fibroblasts from FA patients to: (1) catalase or
superoxide dismutase, (2) low-molecular-weight antioxidants, or (3)
decreased oxygen levels.10-14 A G2 cell cycle delay, observed in FA cells, was counteracted by culturing cells in 5%
O2,15 and a major role was suggested for free
iron in inducing G2 arrest in FA cells.16 The
report by Takeuchi and Morimoto7 provided evidence for
excess oxidative DNA damage (8OHdG) in FAA cells challenged with
H2O2 that was related, at least in part, to
catalase deficiency. A recent report by Ruppitsch et al17
provided elegant evidence for the loss of both MMC and diepoxybutane
(DEB) sensitivity of FAA cells transfected with cDNA causing
overexpression of thioredoxin, a nonenzymatic antioxidant protein.18 Hence, both exogenous and endogenous
antioxidants can decrease the phenotypic defect of FA cells, both
including O2 and MMC sensitivity. In turn, the action
mechanisms of MMC can either be ascribed to DNA cross-linking or to
redox cycling, as reported in early studies of MMC.19,20
That MMC sensitivity in FA cells may be attributed to redox mechanisms
rather than to DNA cross-linking has been shown by four independent
reports11,13,21,22 focused on as many different endpoints
(chromosomal instability, cytotoxicity, apoptosis, and mutagenesis).
Together, the results of these studies showed that: (1) MMC-induced
toxicity was confined to normoxic conditions which, unlike hypoxia,
were associated to enhanced redox-cycling mechanisms, not to DNA
cross-linking,21,22 and (2) MMC toxicity was both removed
by antioxidant enzymes and by low-molecular-weight
antioxidants.11,13
The observation of redox abnormalities in FA is not confined to in
vitro conditions. A series of ex vivo studies provided evidence for
abnormal O2 metabolism in FA patients and in their parents.
Freshly drawn white blood cells from both FA homozygotes and
heterozygotes produced excess ROS as detected by luminol-dependent chemiluminescence (LDCL),23,24 and displayed excess 8OHdG
levels that were significantly correlated with LDCL as well as with
chromosomal instability.8 Thus, both ex vivo and in vitro
evidence pointed to a direct link between ROS formation, oxidative DNA
damage, and chromosomal breakages in FA.
Based on the available evidence, one might suggest that the
authors1 could carry out a new series of experiments by
exposing Fac In conclusion, the current view attributing the FA-associated defect(s)
to the phenotypic sensitivity to MMC and DEB related to cross-linking
mechanisms may be viewed as a fading dogma relying on the definition of
FA as a DNA repair disorder. While no conclusive evidence has thus far
related FA gene products to any function in DNA repair, a thriving body
of evidence has associated MMC (and DEB) sensitivity to an impairment
of redox balance in FA cells, both in vitro and in vivo. This evidence
should no longer be disregarded in the forthcoming studies of FA.
Giovanni Pagano
Adriana Zatterale
Ludmila G, Korkina
1.
Carreau M, Gan OI, Liu L, Doedens M, McKerlie C, Dick JE, Buchwald M:
Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Blood
91:2737, 1998
2.
Joenje H, Youssoufian H, Kruyt FAE, dos Santos C, Wevrick R, Buchwald M:
Expression of the Fanconi anemia gene FAC in human cell lines: Lack of effect of oxygen tension.
Blood Cells Mol Dis
21:182, 1995[Medline]
[Order article via Infotrieve]
3.
Saito H, Hammond AT, Moses RE:
The effect of low oxygen tension on the in vitro replicative life span of human diploid fibroblast cells and their transformed derivatives.
Exp Cell Res
217:272, 1995[Medline]
[Order article via Infotrieve]
4.
Nakayama K, Nakayama KI, Negishi I, Kuida K, Sawa H, Loh DY:
Targeted disruption of Bcl-2
5.
Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ:
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.
Cell
75:229, 1993[Medline]
[Order article via Infotrieve]
6.
Motoyama N, Wang F, Roth KA, Sawa H, Nakayama KI, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY:
Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice.
Science
267:1506, 1995
7.
Takeuchi T, Morimoto K:
Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency.
Carcinogenesis
14:1115, 1993
8.
Degan P, Bonassi S, De Caterina M, Korkina LG, Pinto L, Scopacasa F, Zatterale A, Calzone R, Pagano G:
In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families.
Carcinogenesis
16:735, 1995
9.
Pagano G, Korkina LG, Brunk UT, Chessa L, Degan P, Del Principe D, Kelly FJ, Malorni W, Pallardó F, Pasquier C, Scovassi I, Zatterale A, Franceschi C:
Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: Prospects for joint research in pharmacology.
Med Hyp
51:253, 1998[Medline]
[Order article via Infotrieve]
10.
Nordenson I:
Effect of superoxide dismutase and catalase on spontaneously occuring chromosome breaks in patients with Fanconi's anemia.
Hereditas
86:147, 1977[Medline]
[Order article via Infotrieve]
11.
Raj AS, Heddle JA:
The effect of superoxide dismutase, catalase and L-cysteine on spontaneous and on mitomycin C induced chromosomal breakage in Fanconi's anemia and normal fibroblasts as measured by the micronucleus method.
Mutat Res
78:59, 1980[Medline]
[Order article via Infotrieve]
12.
Joenje H, Arwert F, Eriksson AW, de Koning H, Oostra AB:
Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia.
Nature
290:142, 1981[Medline]
[Order article via Infotrieve]
13.
Nagasawa H, Little JB:
Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts.
Carcinogenesis
4:795, 1983
14.
Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G, Gandini E:
Effect of oxidants and antioxidants on chromosomal breakage in Fanconi's anemia lymphocytes.
Hum Genet
69:62, 1985[Medline]
[Order article via Infotrieve]
15.
Schindler D, Hoehn H:
Fanconi anemia mutation causes cellular susceptibility to ambient oxygen.
Am J Hum Genet
43:429, 1988[Medline]
[Order article via Infotrieve]
16.
Poot M, Gross O, Epe B, Pflaum M, Hoehn H:
Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anemia lymphoblastoid cells.
Exp Cell Res
222:262, 1996[Medline]
[Order article via Infotrieve]
17.
Ruppitsch W, Meisslitzer C, Hirsch-Kauffmann M, Schweiger M:
Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane.
FEBS Lett
422:99, 1998[Medline]
[Order article via Infotrieve]
18.
Kuge S, Jones N:
YAP1-dependent activation of TRX2 is essential for the response of Saccharomyces cerevisiae to oxidative stress by hydroperoxides.
EMBO J
13:655, 1994[Medline]
[Order article via Infotrieve]
19.
Gutteridge JMC, Quinlan GJ, Wilkins S:
Mitomycin C-induced deoxyribose degradation inhibited by superoxide dismutase. A reaction involving iron, hydroxyl and semiquinone radicals.
FEBS Lett
167:37, 1984[Medline]
[Order article via Infotrieve]
20.
Pritsos CA, Sartorelli AC:
Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.
Cancer Res
46:3528, 1986
21.
Clarke AA, Philpott NJ, Gordon-Smith EC, Rutherford TR:
The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking.
Br J Haematol
96:240, 1997[Medline]
[Order article via Infotrieve]
22.
Liebetrau W, Runger TM, Mehling BE, Poot M, Hoehn H:
Mutagenic activity of ambient oxygen and mitomycin C in Fanconi's anaemia cells.
Mutagenesis
12:69, 1997
23.
Rumyantsev AG, Samochatova EV, Afanas'ev IB, Korkina LG, Suslova TB, Cheremisina ZP, Maschan AA, Durnev AD, Lurye BL:
The role of free oxygen radicals in the pathogenesis of Fanconi's anemia.
Ter Arkh
61:32, 1989
24.
Korkina LG, Samochatova EV, Maschan AA, Suslova TB, Cheremisina ZP, Afanas'ev IB:
Release of active oxygen radicals by leukocytes of Fanconi's anemia patients.
J Leukoc Biol
52:357, 1992[Abstract]
First regarding the references, we believe that one reference
by Takeuchi et al1 was omitted due to formatting of the
paper and was overlooked on our part. The references cited as 37-39 regard the Bcl2 knockout mice and are discussed and referred to later
in the paper.
Second, our paper dealt with mitomycin C (MMC) hypersensitivity of the
Fancc Oxidative DNA damage is repaired by the BER pathway, which may share steps with the crosslink repair pathway. Thus, increased sensitivity of FA cells to MMC caused by either oxidative damage or crosslinks, or both, support the notion of an altered repair mechanism. We did, however, discuss the possible effect of ROS formation in the
toxicity of MMC. Although MMC is known to induce a wide variety of
lesions in the DNA, several papers have described the inability of FA
cells to repair crosslinked DNA as the principal cause of MMC
sensitivity. Again, we do not dismiss ROS formation as a
possible mechanism in the toxicity of MMC in the
Fancc Until we find the true function of the FA proteins, one can only speculate on the defects present in FA cells.
Madeleine Carreau
1. Takeuchi T, Morimoto K: Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis 14:1115, 1993
2.
Fujiwara Y, Nakamura M, Yokoo S:
A new anticancer platinum compound, (
3.
Hang B, Yeung AT, Lambert MW:
A damage-recognition protein which binds to DNA containing interstrand cross-links is absent or defective in Fanconi anemia, complementation group A cells.
Nuclic Acids Res
21:4187, 1993
4.
Yamashita T, Kupfer G, Naf D, Suliman A, Joenje H, Asano S, D'Andrea AD:
The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.
Proc Natl Acad Sci USA
95:13085, 1998
5.
Escarceller M, Buchwald M, Singleton B, Jeggo P, Jackson S, Moustacchi E, Papadopoulo D:
Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
J Mol Biol
279:375, 1998[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 1999 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||